Small Business Health IT & Life Sciences grant
Chemosense is awarded a GSI and Commerce Small Business Health IT & Life Sciences grant.
The Problem
2
Cause of death (cancer)
606,520
Estimated cancer deaths in the US in 2020
4
Success rate of new first-in-human oncology drugs
The Solution
Repurposing existing drugs as novel cancer therapeutic
Drug repurposing or repositioning is a strategy of finding new indications for already known marketed drugs used in various clinical settings. This can give new life to drugs currently used in the clinic, or shelved drugs that failed initial tests for their main indication. This strategy has immense promise over the existing strategy of developing novel first-in-human compounds.
Cost Effective
Costs approximately 8x less to repurpose a drug for a new indication than to develop a novel drug.
Quick Translation
Previous clinical trial data and years of use in humans allows repurposed drugs to move more quickly to market.
Higher Success Rate
In recent years, 30% of newly FDA approved drugs were repurposed drugs.
“Chemosense’s mission is to promote the survival and wellbeing of people suffering from cancer through the development of powerful new therapies.”
TeamChemosense
